NCT01088178

Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period

Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period: A Prospective, Randomized Pilot Study of Three Time Intervals

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: United States Naval Medical Center, Portsmouth · Federal
• Sex: Female
• Age: 16 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The investigators study is a prospective randomized trial of women undergoing the levonorgestrel intrauterine system (LNG-IUS: Mirena©, Bayer) at three separate time periods: immediate post placental (IPP) defined as insertion within 10 min delivery of placenta, early post partum (EP) defined as insertion after 10 min but within 72hrs postpartum, or interval (INT) insertion defined as insertion after 6wks postpartum. This is a pilot study in preparation for a multicenter, prospective randomized study of long-acting reversible contraception in the postpartum period.

Conditions

• Contraception

Interventions

Type	Name	Description
DEVICE	Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer)	Placement of Mirena at given intervals during the postpartum period

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-05-01
• Completion: 2010-07-01
• First posted: 2010-03-17
• Last updated: 2025-07-20

Locations

1 site across 1 country: United States